Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its price target lowered by analysts at Piper Sandler from $10.00 to $6.00. They now have an "overweight" rating on the stock.
Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025 [Yahoo! Finance]